Considering that the levels of PD severity are due to different rates of disease progression, such as the age of onset, cognitive impairment, or PD subtype, no correlation between plasma NTN‐1 and disease course may result from the heterogeneous composition of the disease. The gene discussed is NTN1; the disease is Cognitive impairment.